Understanding cancer biology in Latino gastric tumors
Official title: Cancer biology and pre-clinical studies of BRCAness in Latino gastric tumors
Funded at University of California at Davis · NIH-11064625 · Data updated 2026-11-12
This study is looking to create new models of gastric cancer from Latino patients to learn more about how the disease develops and to test current treatments, with the hope that this research will lead to better care for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California at Davis NIH-funded |
| Lab location | 1 site (Davis, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $129,653 |
| NIH project number | 3U54CA283766-02S2 |
| Project ID | NIH-11064625 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Latino individuals diagnosed with gastric cancer or those at high risk for developing it.
✕Less likely to help
Patients who do not identify as Latino or those with other types of cancer may not receive direct benefits from this research.
What this research studies
This research focuses on developing and characterizing new patient-derived xenografts (PDXs) from Latino populations to better understand gastric cancer. By using these PDX models, researchers aim to investigate the biological mechanisms behind cancer development and test existing cancer therapies. The study involves collaboration among multiple cancer centers to ensure a diverse representation of patients and to address health disparities in cancer treatment. Patients may have the opportunity to contribute to this important work and potentially benefit from advancements in precision medicine.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized treatments for gastric cancer in Latino patients.
How similar studies have gone: Previous research has shown success in using patient-derived xenografts to study cancer biology and test therapies, indicating a promising approach for this study.
Where this research is happening
-
University of California at Davis
Davis, United States Active
Researchers
- Principal investigator: Carvajal Carmona, Luis Guillermo — University of California at Davis
- Study coordinator: Carvajal Carmona, Luis Guillermo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.